06/12/2019

HARTMANN starts strategy implementation with a comprehensive transformation program:

Focus on innovative strength, competitive strength and process efficiency. The HARTMANN GROUP is starting to implement a new five-year strategic program to strengthen its competitiveness and secure a leading international market position in the three core segments of Wound, Incontinence and Infection Management.
Learn more
05/08/2019

HARTMANN expands advanced wound care offering with acquisition of Safran Coating

Hartmann moves to extend its product portfolio for advanced wound care with strategic investment in silicone technology and innovations // Safran Coating is one of Europe’s leading and most innovative suppliers of silicone technologies for healthcare, a main driver for growth in advanced wound care
Learn more
02/08/2019

HARTMANN GROUP achieves sales growth of 3.7% in the first half of 2019

The HARTMANN GROUP, one of the leading international suppliers of medical and hygiene products, increased sales revenues by 3.7% to EUR 1.075 billion in the first half of 2019. All segments generated higher sales. The Wound Management segment has developed particularly dynamically and was an additional growth factor. With innovative wound care...
Learn more
10/05/2019

HARTMANN GROUP starts the 2019 financial year with a 4% rise in sales

Sales revenues in all segments are up on the previous year – above-average growth in Wound Management driven by innovations / EBIT at EUR 30.6 million virtually the same as last year (EUR 31.3 million) / Targets confirmed for the 2019 year as a whole – focus remains on strengthening competitive position and customer orientation
Learn more
20/03/2019

The HARTMANN GROUP reaches 2018 sales and earnings goal

The HARTMANN GROUP has coped well with the global market challenges during the 2018 financial year. Despite an unfavorable exchange rate development, persistently high regulatory expenses and increasing pressure on prices and margins across the industry, an increase in sales of 2.9 % and, influenced by these challenges, an EBIT of EUR 123.2...
Learn more
Show More